Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Influence of low molecular weight heparin (certoparin) and unfractionated heparin on the release of cytokines from human leukocytes.

K├Âller M, Kutscha-Lissberg F, Brom J, Weidinger G, Muhr G.

Inflammation. 2001 Oct;25(5):331-7.

PMID:
11820460
2.

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Verstraete M.

Drugs. 1990 Oct;40(4):498-530. Review.

PMID:
1964634
3.

From unfractionated heparins to low molecular weight heparins.

Hirsh J.

Acta Chir Scand Suppl. 1990;556:42-50. Review.

PMID:
1705072
4.

Update on low molecular weight heparins at the beginning of third millennium. Focus on reviparin.

Del Bono R, Martini G, Volpi R.

Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):950-9. Review.

PMID:
21845806
5.

The heparins and cancer: review of clinical trials and biological properties.

Castelli R, Porro F, Tarsia P.

Vasc Med. 2004 May;9(3):205-13. Review.

PMID:
15675186

Supplemental Content

Support Center